LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/2-Stage vs Irrigation for Infections in Unresectable Joints
Large Joints and Extremities

2-Stage vs Irrigation for Infections in Unresectable Joints

April 2, 2018 2 min read Premium comments

Advertisement

2-Stage vs Irrigation for Infections in Unresectable Joints
Photo creation by RRY Publications, LLC, Wikimedia Commons and Dave Haygarth
#periprostheticjointinfectionSecondary#knee#hip

What happens when patients with periprosthetic joint infection (PJI) undergo irrigation and debridement (I&D) instead of a two-stage exchange procedure?

A new unpublished study, “Outcomes of Irrigation and Debridement of Unresectable Revision Arthroplasty in Periprosthetic Joint Infection”, attempts to find an answer.

Co-author John R. Martin, M.D. told OTW, “The following study was performed to assess the clinical outcomes of patients that were treated for infection following total joint replacement in which the implants were deemed ‘unresectable.’”

“For most patients, this included revision components or extensive hardware that would be extremely debilitating or difficult to reconstruct if the implants were removed. Therefore, an I&D was performed on each patient at the discretion of the revising surgeon rather than attempting a two-stage replacement.”

“Two-stage exchange arthroplasty is currently the gold standard for treating infected total joint replacements in the United States. However, with increasing bone loss, revision constructs, and soft tissue loss, the risks of a two-stage procedure may potentially outweigh the benefits. As the clinical picture increases in complexity for this patient population, the more limited the treatment options become.”

“When patients typically reach this ‘unresectable’ stage, the goal of care in a shared-decision model change from infection eradication to keeping their implant and preserving function. In many of these patients that are considered ‘unresectable’ by the treating surgeon, irrigation and debridement may represent one of the last surgical options of preserving the patient’s limb. Therefore, we sought to report the clinical results of this patient population with an attempt at limb preservation.”

“Only about 5% of periprosthetic joint infections were deemed ‘unresectable.’ This cohort represented a very complex patient population with most patients having several revisions prior to their irrigation and debridement procedure. Approximately, 50% of patients required reoperation for infection. Very few patients had implant removal at the time of final follow-up. Finally, the majority of patients remained on chronic suppression at the final follow-up. Chronic antibiotic suppression is a desirable goal to allow patients to retain their implant and we do not consider these cases ‘failures.’”

Aldo M. Riesgo, M.D. co-author on the study and fellow with the Department of Orthopaedic Surgery at Cleveland Clinic Florida, told OTW, “The results of irrigation and debridement in this ‘unresectable’ cohort were relatively high but were not too different from patients with an infected primary total joint replacement undergoing irrigation and debridement.”

“Approximately 50% of patients will require a reoperation and the vast majority of patients will require chronic suppression. However, there are limited treatment options available. Irrigation and debridement was noted to have a low complication and mortality rate with a high success for limb salvage as an endpoint. We recommend selective use of irrigation and debridement for very complex cases in which the hardware or implants have been deemed ‘unresectable’ and the risks of the two-stage procedure outweigh the potential benefits.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy